is tirzepatide worth the extra money New Pricing, Access to Available Through Self-Pay Options NewSelf vs. Ro (I Tried

Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes For the primary endpoint, retatrutide lowered A1C by an average of 1.7% to 2.0% across doses at 40 weeks in TRANSCEND-T2D-1 Participants taking retatrutide 12 mg lost an average of 36.6 lbs (16.8%) No weight loss plateau was observed with retatrutide, with participants continuing their weight loss trajectory through 40 weeks 1,2 For the primary endpoint, participants taking retatrutide achieved average A1C reductions of up to 2.0%, using the efficacy estimand

Product introduction Rybelsus 3mg Tablet is a prescription medicine used to improve blood sugar (glucose) in adults with type 2 diabetes

The medicine does not interfere with the bodys normal clotting system

Pillai, V

Prioritize Patient Privacy: Follow HIPAA guidelines strictly